NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87 | -28.1% | 67,548 | 0.0% | 0.00% | – |
| Q2 2023 | $121 | +21.0% | 67,548 | 0.0% | 0.00% | – |
| Q1 2023 | $100 | +5.3% | 67,548 | -0.0% | 0.00% | – |
| Q4 2022 | $95 | -99.9% | 67,560 | -0.8% | 0.00% | – |
| Q3 2022 | $187,000 | -41.6% | 68,089 | 0.0% | 0.00% | – |
| Q2 2022 | $320,000 | -9.6% | 68,089 | -6.6% | 0.00% | – |
| Q1 2022 | $354,000 | -59.0% | 72,886 | -49.4% | 0.00% | – |
| Q4 2021 | $864,000 | +72.5% | 143,912 | +93.5% | 0.00% | – |
| Q3 2021 | $501,000 | +62.1% | 74,365 | +93.3% | 0.00% | – |
| Q2 2021 | $309,000 | -18.9% | 38,462 | +1.0% | 0.00% | – |
| Q1 2021 | $381,000 | -19.6% | 38,079 | -12.6% | 0.00% | – |
| Q4 2020 | $474,000 | +16.5% | 43,551 | -6.2% | 0.00% | – |
| Q3 2020 | $407,000 | +91.1% | 46,411 | +367.1% | 0.00% | – |
| Q2 2020 | $213,000 | -1.4% | 9,936 | +70.0% | 0.00% | – |
| Q1 2020 | $216,000 | -75.2% | 5,843 | -62.3% | 0.00% | – |
| Q4 2019 | $872,000 | +1457.1% | 15,479 | +738.5% | 0.00% | – |
| Q3 2019 | $56,000 | -59.4% | 1,846 | -81.5% | 0.00% | – |
| Q2 2019 | $138,000 | – | 9,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 1,676,884 | $18,278,000 | 19.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 130,000 | $1,417,000 | 0.82% |
| Lion Point Capital, LP | 300,000 | $3,270,000 | 0.63% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 34,285 | $374,000 | 0.59% |
| Orbimed Advisors | 2,711,013 | $29,550,000 | 0.26% |
| DAFNA Capital Management LLC | 65,000 | $709,000 | 0.21% |
| Virtus ETF Advisers LLC | 23,985 | $261,000 | 0.11% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 31,357 | $342,000 | 0.11% |
| Krensavage Asset Management, LLC | 30,292 | $330,000 | 0.10% |
| Ikarian Capital, LLC | 200,000 | $2,179,000 | 0.10% |